Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-19-054103

CEO and Chairman acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2019-10-23 Option exercise +20,000 $0.33 $6,600 1,878,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2019-10-23 Option exercise · Stock Option (Right to Buy) −20,000 780,000 D
Loading xslF345X03/doc4.xml…